Tudor Investment Corp’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $115M | Buy |
124,672
+77,914
| +167% | +$79M | 0.21% | 68 |
|
|
2025
Q4 | $50.2M | Buy |
+46,758
| New | +$44.7M | 0.09% | 164 |
|
|
2025
Q2 | – | Sell |
-54,006
| Closed | -$42M | – | 3539 |
|
|
2025
Q1 | $44.6M | Buy |
54,006
+51,006
| +1,700% | +$42.4M | 0.15% | 76 |
|
|
2024
Q4 | $2.32M | Buy |
+3,000
| New | +$2.48M | 0.01% | 1160 |
|
|
2024
Q3 | – | Sell |
-1,510
| Closed | -$1.36M | – | 2933 |
|
|
2024
Q2 | $1.37M | Buy |
+1,510
| New | +$1.21M | 0.01% | 1292 |
|
|
2024
Q1 | – | Sell |
-23,739
| Closed | -$16.9M | – | 2529 |
|
|
2023
Q4 | $13.8M | Buy |
23,739
+12,993
| +121% | +$7.58M | 0.11% | 231 |
|
|
2023
Q3 | $5.77M | Buy |
+10,746
| New | +$5.54M | 0.06% | 438 |
|
|
2023
Q2 | – | Sell |
-15,198
| Closed | -$6.37M | – | 2714 |
|
|
2023
Q1 | $5.22M | Sell |
15,198
-48,047
| -76% | -$16.2M | 0.08% | 354 |
|
|
2022
Q4 | $23.1M | Buy |
63,245
+42,940
| +211% | +$15.2M | 0.46% | 11 |
|
|
2022
Q3 | $6.57M | Buy |
20,305
+33
| +0.2% | +$10.5K | 0.14% | 149 |
|
|
2022
Q2 | $6.57M | Sell |
20,272
-185
| -0.9% | -$55.5K | 0.17% | 119 |
|
|
2022
Q1 | $5.86M | Buy |
20,457
+9,045
| +79% | +$2.33M | 0.14% | 174 |
|
|
2021
Q4 | $3.15M | Buy |
11,412
+1,530
| +15% | +$388K | 0.05% | 430 |
|
|
2021
Q3 | $2.28M | Buy |
9,882
+1,002
| +11% | +$247K | 0.04% | 630 |
|
|
2021
Q2 | $2.04M | Sell |
8,880
-48,843
| -85% | -$9.81M | 0.04% | 558 |
|
|
2021
Q1 | $10.8M | Buy |
+57,723
| New | +$11.3M | 0.22% | 68 |
|
|
2020
Q4 | – | Sell |
-11,644
| Closed | -$1.72M | – | 1499 |
|
|
2020
Q3 | $1.72M | Buy |
+11,644
| New | +$1.8M | 0.08% | 352 |
|
|
2019
Q3 | – | Sell |
-75,739
| Closed | -$8.39M | – | 1229 |
|
|
2019
Q2 | $8.39M | Buy |
+75,739
| New | +$8.92M | 0.24% | 41 |
|
|
2019
Q1 | – | Sell |
-59,043
| Closed | -$6.83M | – | 1195 |
|
|
2018
Q4 | $6.83M | Sell |
59,043
-13,886
| -19% | -$1.55M | 0.14% | 34 |
|
|
2018
Q3 | $7.83M | Buy |
72,929
+21,772
| +43% | +$2.18M | 0.2% | 58 |
|
|
2018
Q2 | $4.37M | Buy |
51,157
+3,615
| +8% | +$297K | 0.15% | 93 |
|
|
2018
Q1 | $3.68M | Buy |
+47,542
| New | +$3.83M | 0.12% | 80 |
|
|
2017
Q3 | – | Sell |
-2,968
| Closed | -$244K | – | 1183 |
|
|
2017
Q2 | $244K | Sell |
2,968
-1,032
| -26% | -$84.2K | 0.01% | 825 |
|
|
2017
Q1 | $336K | Sell |
4,000
-14,158
| -78% | -$1.13M | 0.01% | 936 |
|
|
2016
Q4 | $1.34M | Buy |
18,158
+10,058
| +124% | +$749K | 0.03% | 261 |
|
|
2016
Q3 | $650K | Sell |
8,100
-3,244
| -29% | -$260K | 0.02% | 601 |
|
|
2016
Q2 | $893K | Sell |
11,344
-3,563
| -24% | -$268K | 0.02% | 503 |
|
|
2016
Q1 | $1.07M | Sell |
14,907
-300,574
| -95% | -$22.7M | 0.03% | 479 |
|
|
2015
Q4 | $26.6M | Buy |
315,481
+290,773
| +1,177% | +$24.1M | 0.75% | 22 |
|
|
2015
Q3 | $2.07M | Sell |
24,708
-233,692
| -90% | -$19.7M | 0.07% | 186 |
|
|
2015
Q2 | $21.6M | Sell |
258,400
-100,500
| -28% | -$7.66M | 0.63% | 33 |
|
|
2015
Q1 | $26.1M | Buy |
358,900
+148,100
| +70% | +$10.5M | 0.83% | 12 |
|
|
2014
Q4 | $14.5M | Buy |
210,800
+151,800
| +257% | +$10.2M | 0.51% | 20 |
|
|
2014
Q3 | $3.83M | Sell |
59,000
-301,300
| -84% | -$19.1M | 0.14% | 84 |
|
|
2014
Q2 | $22.4M | Buy |
360,300
+355,600
| +7,566% | +$21.2M | 0.86% | 15 |
|
|
2014
Q1 | $277K | Sell |
4,700
-5,700
| -55% | -$318K | 0.01% | 864 |
|
|
2013
Q4 | $530K | Buy |
10,400
+3,800
| +58% | +$190K | 0.03% | 514 |
|
|
2013
Q3 | $332K | Sell |
6,600
-4,100
| -38% | -$215K | 0.01% | 544 |
|
|
2013
Q2 | $526K | Buy |
+10,700
| New | +$582K | 0.04% | 312 |
|
Other funds holding LLY
VCM
VPM
Tudor Investment Corp's LLY Position: Q1 2026 in Review
Tudor Investment Corp increased its Eli Lilly (LLY) stake by 167% in Q1 2026, buying an estimated $79M and bringing the position to 124,672 shares worth $115M. The position accounts for 0.21% of the portfolio, ranked #68.
Tudor Investment Corp first reported a position in LLY in Q2 2013 and has held it in 39 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Tudor Investment Corp held 124,672 shares of Eli Lilly worth $115M as of Q1 2026.
- Tudor Investment Corp bought 77,914 Eli Lilly shares in Q1 2026, an estimated $79M.
- Eli Lilly made up 0.21% of Tudor Investment Corp's portfolio in Q1 2026, its #68 holding.
- Tudor Investment Corp first reported a position in Eli Lilly in Q2 2013 and has held it in 39 quarters since.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.